Breast Cancer: From Bench to Personalized Medicine / edited by Saima Shakil Malik, Nosheen Masood

Contributor(s):

Resource type: Ressourcentyp: Buch (Online)Book (Online)Language: English Publisher: Singapore : Springer Nature Singapore, 2022Publisher: Singapore : Imprint: Springer, 2022Edition: 1st ed. 2022Description: 1 Online-Ressource(XVII, 536 p. 1 illus.)ISBN:

9789811901973

Subject(s):

Additional physical formats: 9789811901966 | 9789811901980 | 9789811901997 | Erscheint auch als: 9789811901966 Druck-Ausgabe | Erscheint auch als: 9789811901980 Druck-Ausgabe | Erscheint auch als: 9789811901997 Druck-AusgabeDOI: DOI: 10.1007/978-981-19-0197-3Online resources:

Summary: Module 1_Overview of Breast Cancer -- Module 2_Cell and Molecular Biology of Breast Cancer-Diagnosis and Prognosis -- Module 3_Breast Cancer Treatment.Summary: This book provides detailed information on the etiology, pathogenesis, diagnosis, prognosis, and treatment strategies for breast cancer. The first section of the book presents epidemiology, risk factors, histopathological, immunohistochemistry, and molecular subtypes of breast cancer based on the receptor status. It also discusses the association of breast cancer with other hormone-sensitive cancers. The second section of the book covers cover BRCA1 and BRCA2-associated breast carcinogenesis, early-stage progression of breast cancer, and noninvasive biomarkers for the early detection of breast cancer. It also discusses the role of epigenetic modifications and non-coding RNAs in breast cancer metastasis and explores these as the biomarkers and therapeutic targets for breast cancer therapy. Further, it discusses the role of fibrinolytic mechanisms and circulating tumor cells in breast cancer diagnosis, prognosis, and treatment. The book also provides an update on oral poly(ADP-ribose) polymerase (PARP) inhibitors to treat breast cancer. Finally, it offers potential new options for personalized therapies for breast cancer patients, including optimizing drug dosage and identifying genetic changes associated with cancer symptom occurrence and severity.PPN: PPN: 1802135707Package identifier: Produktsigel: ZDB-2-SBL | ZDB-2-SEB | ZDB-2-SXB

Holdings ( 0 )

No physical items for this record